Orbimed Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $5.66 Million - $7.89 Million	432,934 Added 18.62%	2,758,434 $43.4 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $7.58 Million - $12.7 Million	745,600 Added 47.19%	2,325,500 $32.5 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $5.79 Million - $10.6 Million	594,000 Added 60.25%	1,579,900 $27.2 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $4.1 Million - $6.18 Million	334,117 Added 51.26%	985,900 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $3.88 Million - $5.45 Million	289,783 Added 80.05%	651,783 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $6.18 Million - $10.7 Million	362,000 New	362,000 $6.36 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.